Cargando…
DISCOVERY OF NOVEL ANTI-SERUM ALBUMIN VHH AS A BUILDING BLOCK FOR PK PROLONGATION
BACKGROUND: The serum half-life of endogenous albumin is approximately 19 days in humans and 1.5-2.5 days in rodents. This extended half-life in vivo is primarily due to effective recycling upon internalization mediated by the neonatal Fc receptor (FcRn). Many protein therapeutics smaller than 60 kD...
Autores principales: | Chen, Yunying, Lin, Xin, Qin, Yi, Wu, Donghui, Gu, Jijie, Nie, Siwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370437/ http://dx.doi.org/10.1093/abt/tbad014.011 |
Ejemplares similares
-
DISCOVERY OF A CYNOMOLGUS MONKEY-CROSS-REACTIVE ANTI-HUMAN CD3 MAB FOR T CELL ENGAGERS
por: Mei, Qin, et al.
Publicado: (2023) -
Blocking phospholamban with VHH intrabodies enhances contractility and relaxation in heart failure
por: De Genst, Erwin, et al.
Publicado: (2022) -
Prolonged Prophylactic Protection from Botulism with a Single Adenovirus Treatment Promoting Serum Expression of a VHH-Based Antitoxin Protein
por: Mukherjee, Jean, et al.
Publicado: (2014) -
Discovery of cyclohexadepsipeptides with anti-Zika virus activities and biosynthesis of the nonproteinogenic building block (3S)-methyl-l-proline
por: Yuan, Bochuan, et al.
Publicado: (2021) -
GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery
por: van Schie, Loes, et al.
Publicado: (2023)